Bioasis Technologies Inc. V.BTI

Bioasis Connections

[JDavenport]

For many years I have followed the work of the noted medical oncologist, Dr. Nancy U. Lin.  I have in my files copies of her papers that relate to the state of cancer treatments over the years.

 

Her name is on a new paper released on June 7, 2022. The paper is called, "Systemic Therapy for HER2-Positive Metastatic Breast Cancer: Moving Into a New Era. This paper is worth reading as an overview of the current state of HER+ breast cancer treatment.

 

Notice that one of the authors of the paper is Dr. Javier Cortes, a member of the Bioasis Medical Advisory Board.

 

The authors of this paper are very influential people as evidenced by their disclosures of potential conflicts of interests, which are standard disclosures on scientific papers and can be found toward the bottom of the paper. These people are very broadly engaged in the oncology space. 

 

Have a look at Nancy Lin's disclosure Consulting or Advisory Roles:

Seattle Genetics

Puma Biotechnology

Daiichi Sankyo

Denali Therapeutics

AstraZeneca

Prelude Therapeutics

Voyager Therapeutics

Affinia Therapeutics

Pfizer

Olema Pharmaceuticals

Aleta Biotherapeutics

Artera

 

And then take a look at Dr. Cortez's Consulting or Advisory Roles:

Celgene

Cellestia Biotech

AstraZeneca

Roche

Seattle Genetics

Daiichi Sankyo

ERYTECH Pharma

Polyphor

Athenex

Lilly

SERVIER

Merck Sharp & Dohme

GlaxoSmithKline

Leuko

Clovis Oncology

Bioasis

Ellipses Pharma

Boehringer Ingelheim

HiberCell

Bioinvent

GEMoaB

Gilead Sciences

Menarini

Zymeworks

Reveal Genomics

 

Why should we have any interest in these associations? Because all of the authors are consultants and advisers to many of the top pharmaceutical companies engaged in breast cancer research and development. In addition to being on the Bioasis Medical Advisory Board, Dr. Cortez lists 24 other companies with whom he advises and consults. These companies include Daiichi Sankyo and AstraZeneca, both of which have done studies with Bioasis. 

 

Bioasis has many secret things going on. How many companies on Dr. Cortez's list, and on the other lists, are already in some sort of relationship with Bioasis? I wouldn't exclude any company right now, especially companies that have known relationships with people who are directly associated with Bioasis, which Dr. Cortez most certainly is.

 

Note, also, that Dr. Cortez is listed as the correspondent for this paper, meaning that enquiries about the paper should be directed to him. This reference is on Page 9 of the paper's PDF file. (The PDF is embedded and may be more easily read if it's downloaded first.)

 

Meanwhile, mark this post, or save a link to the paper. I think it's very possible that there may be names in those lists that may appear in Bioasis's future. The connections are there. xB3-001 plays right into the breast cancer space and may one day enable treatment of one of the major concerns expressed in the paper, HER2+ brain tumours.

 

Bioasis is massively connected. It has multiple relationships and collaborations already announced. Don't bother telling us that there's nothing going on. 

 

jd

[JDavenport]

I see so many things at Bioasis to leverage into valuable initiatives. I understand how much hope there is in that. But when I see a lousy press release like the Cresence PR, that didn't anticipate for a moment that it could mean to shareholders that xB3 is being back-shelved, or lowered in importance, which it's not, then I wonder whether there is a thought of any kind being given to

[beenthere]

I wish we could be all as smart as you ! Of course,the oblivious question would be ............. if you are So smart why are you so poor?! I can tell ... you are hoping that BTI can pull it off and .... you can say ...see I told you! ...........  not going to happen!

[JDavenport]

Yes, beenthere, that was an "oblivious" question. Totally cracked me up. jd

[frohlir944]

Beenthere......totally oblivious! Easilly your best post ever! Keep up the hard work.....but dont hurt yourself.....I can parctically hear the gears turning. Really looking forward to more entertainment.

[Aarcor]

Public companies that have an interest in future funding do not want to have anything positive left to the public to decipher. All the speculation over the last decade about what/who may be linked or not linked and what may or may not be happening in the background is garbage.  Competent management finds ways to make positive developments straightforward to interpret.  This in turn

[JDavenport]

This post of Aarcor's is one of the most refreshing posts I've read in a while. I suspect that Aarcor and I would debate a couple of minor points in the post but I truly admire and respect the thought put into it. About the last ten years, early on, it never occured to me that management and BoD could be so inadequate for so long. I pitched and posted and argued personally for a true

[KayakerBC]

This post of Aarcor's is one of the most refreshing posts I've read in a while. Uh huh.  More whining and complaining about the past 10 years.  As if any of that is the fault of the current CEO.  Like any of it sounds better the 47th time I've heard it.   And this fantasy that if we could just get rid of the current CEO and board everything would be sooooooooooooo

[beenthere]

Hey! KBC! You are NOT allowed to talk like that to the BTI Supreme Leader!  lol But yes I have to say I thought it was tres funny forJD to post and agree with Arcor's post! A first for sure! It fits  very well with some of my recent posts!   JD has  lost I!  Plain and  simple!

[beenthere]

Like Donald Trump .....we can hope they both self-destruct! ..... .... or the very least ......just go away!

[JDavenport]

beenthere, obliviously, thinks it a surprise that I would agree with Aarcor who posted some clear thoughts and not personal attacks.   Aarcor essentially posted what I have stated for about 10 years. Management made mistakes and they're still making them. That's not a vote against xB3 or its prospects and it's doesn't criticize everything that Bioasis appears to be doing

[JDavenport]

I don't recommend getting rid of the current CEO. I don't like the secrets, some of which are not being well kept, and I don't think much of how the company is being presented. I think the corporate presentation is being used for disclosure manipulation and obfuscation.But I do support the initiatives. Voting out DrDR would disrupt a number of those good initiatives. But she can do

[narmac]

,,just a gut feeling but I put more money down this past week that we get some meaty news well before any attempt to gain access to the Nasdaq. Xb3-001 is my personal pet peeve here,,,,,,,why this platform hasnt been pushed into the clinic is almost ,,,, well maybe criminal,,,,,,JMO......! ,,,but we all know when the planets align this stock is off to daahhhhhhhhh moooooooon!!,,,maybe even

[KayakerBC]

 Xb3-001 is my personal pet peeve here,,,,,,,why this platform hasnt been pushed into the clinic is almost ,,,, well maybe criminal,,,,,,JMO......! "....Many of you will be asking about Bioasis neuro-oncology assets, in particular XB3-001. As indicated at our 2020 shareholders meeting, the board took the strategic decision to pause that program and to divest or out-license XB3-001. This

[JDavenport]

KayakerBC, as some shareholders learned by mistake at the Vancouver airport gathering, the quote you presented from the subsequent Zoom meeting contains a falsehood. Either that or a revelation made at the airport was a falsehood, but because it was revealed in a Bioasis document, by mistake, I would tend to believe the airport statement. I have a copy of that document, as the attendees and likely

[JDavenport]

I have reconsidered my statement that the quote posted by KayakerBC contains a falsehood. It doesn't but it does attempt to direct attention away from xB3-001. The part of the quote I take some exception to is this:   "...the board took the strategic decision to pause that program and to divest or out-license XB3-001. This was not because of any lack of faith in the asset. Quite

[KayakerBC]

....That could mean that the company has been engaged with potential partners but it doesn't exclude the likelihood that discussions have come down to one partner, who is doing work, but with whom there is no agreement in place to sell or out-license xB3-001. That would be what "discussions are ongoing" could be about. This is the scenario that I believe has happened.   So it

[JDavenport]

Yep, I know all that stuff, but the company could offer far better representations in its filings, corporate presentations, press releases and on the website. I'll stick with my opinions about this. I will not make excuses for them. I talk privately with many shareholders. Almost every call contains questions about whether Bioasis is doing anything, why don't they tell us anything, what

[JDavenport]

I once said on this forum that if I ever went rogue, I could make cases for a lot of things that would put the usual trolls to shame. They don't know enough to be effective. I do. After 14 years, over three of them with DrDR, we're at18¢, and this year, which is half over, is going to be great, they say. It could be true, but 18¢ says that people don't believe it and that is

[ronrydell]

JD and Kayde wrote some great posts for this mornings consumption....I'm now informed about the flagship component X3b-001 and have some renewed faith in the company. A reasonable gamble. One must note that only those holding one million shares plus will have a reasonable chance of making some long term money....(ie 33K shares at, say, $10 per share on NASDAQ gives one only $333K dollars

[KayakerBC]

One must note that only those holding one million shares plus will have a reasonable chance of making some long term money....(ie 33K shares at, say, $10 per share on NASDAQ gives one only $333K dollars...discounted for inflation and time...doesn't amount to that much. Looks like you're applying a 1 for 30 rollback to your calcs -- 1,000,000 / 30 = ~33K shares. I would quibble with your

[MBT123]

John Broke you and your messages are a "joke" how you could  ever lay your head down at night in your trailer and think anyone would care what you thought or researched?? After 10yrs maybe it's not the people it's the actual "product" that's a problem..Too many "research" programs that had no end no follow thru just crickets! John Broke pumped ever

[Aarcor]

Here's BCYakker weighing in again. He has a few general themes that he has gone on about for 10 years as well. He likes to talk about what a bad deal current management has inherited and therefore, we can't expect much.  That's nice, no accountability for the healthy 6 figure part-time salary Rathjen is drawing from the other side of the world.  A positive change is a "